Edition:
India

BiondVax Pharmaceuticals Ltd (BVXV.OQ)

BVXV.OQ on NASDAQ Stock Exchange Capital Market

5.65USD
16 Oct 2019
Change (% chg)

$-0.03 (-0.53%)
Prev Close
$5.68
Open
$5.26
Day's High
$5.65
Day's Low
$5.26
Volume
162
Avg. Vol
1,961
52-wk High
$7.26
52-wk Low
$3.87

Latest Key Developments (Source: Significant Developments)

Biondvax Pharmaceuticals Ltd Reports Qtrly Loss Per Share of NIS 0.01 ‍​
Tuesday, 28 Nov 2017 

Nov 28 (Reuters) - Biondvax Pharmaceuticals Ltd ::BIONDVAX PHARMACEUTICALS LTD - QTRLY LOSS PER SHARE NIS 0.01 ‍​.  Full Article

BiondVax and NIH sign clinical trial agreement for phase 2 trial for universal flu vaccine
Monday, 20 Nov 2017 

Nov 20 (Reuters) - Biondvax Pharmaceuticals Ltd :BiondVax and NIH sign clinical trial agreement for a phase 2 trial in the U.S. with BiondVax's universal flu vaccine.BiondVax Pharmaceuticals - ‍NIAID is submitting IND to FDA, participant recruitment anticipated to begin after end of 2017/18 flu season​.  Full Article

No consensus analysis data available.